after hysterectomy , 156 evaluable patients with stage i ( limited to the corpus ) or stage ii ( limited to the corpus and cervix ) uterine sarcomas were randomly assigned to adjuvant chemotherapy with adriamycin ( adria laboratories , columbus , ohio ) for six months or to no further treatment .
C0227813
corpus
C0338113
uterine sarcomas